{"id":"W2114189419","doi":"10.1016/s0140-6736(09)62125-5","title":"Apixaban versus enoxaparin for thromboprophylaxis after knee replacement (ADVANCE-2): a randomised double-blind trial","year":2010,"lang":"en","type":"article","venue":"The Lancet","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":777,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of Calgary","funders":"Bristol-Myers Squibb","keywords":"Apixaban; Medicine; Deep vein; Pulmonary embolism; Knee replacement; Surgery; Enoxaparin sodium; Adverse effect; Venography; Thrombosis; Rivaroxaban; Low molecular weight heparin; Arthroplasty; Internal medicine; Warfarin; Atrial fibrillation","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003176692,0.004084208,0.009629887,0.0008209868,0.000670913,0.00241094,0.001973305,0.004604016,0.01857021],"category_scores_gemma":[0.003488012,0.002038124,0.004624382,0.000761168,0.002225496,0.002945475,0.0009861848,0.005215735,0.002384557],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00096493,"about_ca_system_score_gemma":0.001178222,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001282692,"about_ca_topic_score_gemma":0.001707679,"domain_scores_codex":[0.9984968,0.0006955778,0.0001380462,0.0003293068,0.00009967422,0.0002406075],"domain_scores_gemma":[0.9981825,0.0006758076,0.0003955823,0.0002207976,0.00009353387,0.0004317828],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9955555,0.0006303581,0.00003779163,0.0005055659,0.0004924217,0.00001706368,0.00001291857,0.00006438069,0.0003238789,0.00005624662,0.0002332872,0.002070605],"study_design_scores_gemma":[0.9948993,0.004410615,0.0001149427,0.00001680975,0.0002454467,0.000008440656,0.000003882385,0.00006729892,0.00003928028,0.00005484235,0.0001334397,0.000005697003],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9324971,0.03314867,0.003345273,0.003253349,0.006442202,0.00956356,0.004502372,0.0007839389,0.006463497],"genre_scores_gemma":[0.9358181,0.01768292,0.006064477,0.003687057,0.005058596,0.01356392,0.002758133,0.0001368932,0.01522996],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01857021,"threshold_uncertainty_score":0.06212354,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05548543360952612,"score_gpt":0.33831639927847,"score_spread":0.2828309656689438,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}